• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪酸氧化障碍的病理生理学。

Pathophysiology of fatty acid oxidation disorders.

机构信息

Department of Pathology & Laboratory Medicine, University of Pennsylvania and Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

出版信息

J Inherit Metab Dis. 2010 Oct;33(5):533-7. doi: 10.1007/s10545-010-9170-y. Epub 2009 Oct 10.

DOI:10.1007/s10545-010-9170-y
PMID:20824345
Abstract

Mitochondrial fatty acid oxidation represents an important pathway for energy generation during periods of increased energy demand such as fasting, febrile illness and muscular exertion. In liver, the primary end products of the pathway are ketone bodies, which are released into the circulation and provide energy to tissues that are not able to oxidize fatty acids such as brain. Other tissues, such as cardiac and skeletal muscle are capable of direct utilization of the fatty acids as sources of energy. This article provides an overview of the pathogenesis of fatty acid oxidation disorders. It describes the different tissue involvement with the disease processes and correlates disease phenotype with the nature of the genetic defect for the known disorders of the pathway.

摘要

线粒体脂肪酸氧化是在能量需求增加的时期(如禁食、发热性疾病和肌肉运动)产生能量的重要途径。在肝脏中,该途径的主要终产物是酮体,它们被释放到循环中,并为不能氧化脂肪酸的组织(如大脑)提供能量。其他组织,如心脏和骨骼肌,可以直接利用脂肪酸作为能量来源。本文概述了脂肪酸氧化障碍的发病机制。它描述了不同组织与疾病过程的关系,并将疾病表型与已知途径遗传缺陷的性质相关联。

相似文献

1
Pathophysiology of fatty acid oxidation disorders.脂肪酸氧化障碍的病理生理学。
J Inherit Metab Dis. 2010 Oct;33(5):533-7. doi: 10.1007/s10545-010-9170-y. Epub 2009 Oct 10.
2
A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation.线粒体脂肪酸β-氧化的生物化学概论。
J Inherit Metab Dis. 2010 Oct;33(5):469-77. doi: 10.1007/s10545-010-9061-2. Epub 2010 Mar 2.
3
Update on mitochondrial fatty acid oxidation disorders.线粒体脂肪酸氧化障碍的最新进展。
J Inherit Metab Dis. 2010 Oct;33(5):467-8. doi: 10.1007/s10545-010-9208-1.
4
Mitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse models.线粒体脂肪酸氧化障碍:小鼠模型的病理生理学研究。
J Inherit Metab Dis. 2010 Oct;33(5):539-46. doi: 10.1007/s10545-010-9121-7. Epub 2010 Jun 8.
5
Disease mechanisms and protein structures in fatty acid oxidation defects.脂肪酸氧化缺陷中的疾病机制和蛋白质结构。
J Inherit Metab Dis. 2010 Oct;33(5):547-53. doi: 10.1007/s10545-010-9046-1. Epub 2010 Feb 12.
6
Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening.线粒体脂肪酸氧化障碍:新生儿筛查前后长链脂肪酸氧化缺陷的临床表型。
J Inherit Metab Dis. 2010 Oct;33(5):527-32. doi: 10.1007/s10545-010-9090-x. Epub 2010 May 7.
7
The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results.线粒体脂肪酸β-氧化的酶学及其在阳性新生儿筛查结果后续分析中的应用。
J Inherit Metab Dis. 2010 Oct;33(5):479-94. doi: 10.1007/s10545-010-9104-8. Epub 2010 May 20.
8
Should the beneficial impact of bezafibrate on fatty acid oxidation disorders be questioned?非诺贝特对脂肪酸氧化紊乱的有益影响是否值得质疑?
J Inherit Metab Dis. 2015 Mar;38(2):371-2. doi: 10.1007/s10545-014-9775-7. Epub 2014 Oct 14.
9
Current issues regarding treatment of mitochondrial fatty acid oxidation disorders.当前线粒体脂肪酸氧化障碍治疗相关问题。
J Inherit Metab Dis. 2010 Oct;33(5):555-61. doi: 10.1007/s10545-010-9188-1. Epub 2010 Sep 10.
10
Clinical and biochemical monitoring of patients with fatty acid oxidation disorders.脂肪酸氧化障碍患者的临床和生化监测。
J Inherit Metab Dis. 2010 Oct;33(5):495-500. doi: 10.1007/s10545-009-9000-2. Epub 2010 Jan 12.

引用本文的文献

1
Diagnostic challenges and outcome of fatty acid oxidation defects in a tertiary care center in Lebanon.黎巴嫩一家三级护理中心脂肪酸氧化缺陷的诊断挑战和结果。
Orphanet J Rare Dis. 2024 Aug 29;19(1):315. doi: 10.1186/s13023-024-03325-4.
2
Medium-chain Acyl-COA dehydrogenase deficiency: Pathogenesis, diagnosis, and treatment.中链酰基辅酶 A 脱氢酶缺乏症:发病机制、诊断与治疗。
Endocrinol Diabetes Metab. 2023 Jan;6(1):e385. doi: 10.1002/edm2.385. Epub 2022 Oct 27.
3
Diagnosis and Management of Inborn Errors of Metabolism in Adult Patients in the Emergency Department.

本文引用的文献

1
3-Hydroxyacyl-coenzyme A dehydrogenase deficiency and hyperinsulinemic hypoglycemia: characterization of a novel mutation and severe dietary protein sensitivity.3-羟基酰基辅酶A脱氢酶缺乏症与高胰岛素血症性低血糖症:一种新突变及严重膳食蛋白敏感性的特征
J Clin Endocrinol Metab. 2009 Jul;94(7):2221-5. doi: 10.1210/jc.2009-0423. Epub 2009 May 5.
2
The paradox of the carnitine palmitoyltransferase type Ia P479L variant in Canadian Aboriginal populations.加拿大原住民群体中肉碱棕榈酰转移酶Ia型P479L变体的悖论。
Mol Genet Metab. 2009 Apr;96(4):201-7. doi: 10.1016/j.ymgme.2008.12.018. Epub 2009 Feb 13.
3
Short-chain acyl-coenzyme A dehydrogenase deficiency.
急诊科成年患者先天性代谢缺陷的诊断与管理
Diagnostics (Basel). 2021 Nov 19;11(11):2148. doi: 10.3390/diagnostics11112148.
4
Biochemical Markers for the Diagnosis of Mitochondrial Fatty Acid Oxidation Diseases.用于诊断线粒体脂肪酸氧化疾病的生化标志物
J Clin Med. 2021 Oct 22;10(21):4855. doi: 10.3390/jcm10214855.
5
Evidence that Oxidative Disbalance and Mitochondrial Dysfunction are Involved in the Pathophysiology of Fatty Acid Oxidation Disorders.证据表明,氧化失衡和线粒体功能障碍与脂肪酸氧化障碍的病理生理学有关。
Cell Mol Neurobiol. 2022 Apr;42(3):521-532. doi: 10.1007/s10571-020-00955-7. Epub 2020 Sep 2.
6
Transcriptome analysis suggests a compensatory role of the cofactors coenzyme A and NAD in medium-chain acyl-CoA dehydrogenase knockout mice.转录组分析表明,辅酶 A 和烟酰胺腺嘌呤二核苷酸(NAD)在中链酰基辅酶 A 脱氢酶敲除小鼠中发挥代偿作用。
Sci Rep. 2019 Oct 10;9(1):14539. doi: 10.1038/s41598-019-50758-0.
7
Health services use among children diagnosed with medium-chain acyl-CoA dehydrogenase deficiency through newborn screening: a cohort study in Ontario, Canada.通过新生儿筛查诊断为中链酰基辅酶 A 脱氢酶缺乏症的儿童的卫生服务利用:加拿大安大略省的一项队列研究。
Orphanet J Rare Dis. 2019 Mar 22;14(1):70. doi: 10.1186/s13023-019-1001-0.
8
Open-label clinical trial of bezafibrate treatment in patients with fatty acid oxidation disorders in Japan.日本非诺贝特治疗脂肪酸氧化障碍患者的开放标签临床试验。
Mol Genet Metab Rep. 2018 Feb 22;15:55-63. doi: 10.1016/j.ymgmr.2018.02.003. eCollection 2018 Jun.
9
Infant with hepatomegaly and hypoglycemia: A setting for fatty acid oxidation defects.患有肝肿大和低血糖的婴儿:脂肪酸氧化缺陷的一种情况。
Indian J Gastroenterol. 2017 Sep;36(5):429-434. doi: 10.1007/s12664-017-0790-0. Epub 2017 Oct 26.
10
Hypoinsulinaemic, hypoketotic hypoglycaemia due to mosaic genetic activation of PI3-kinase.由于PI3激酶的嵌合基因激活导致的低胰岛素血症、低酮血症性低血糖症。
Eur J Endocrinol. 2017 Aug;177(2):175-186. doi: 10.1530/EJE-17-0132. Epub 2017 May 31.
短链酰基辅酶A脱氢酶缺乏症
Mol Genet Metab. 2008 Dec;95(4):195-200. doi: 10.1016/j.ymgme.2008.09.007. Epub 2008 Nov 5.
4
Clinical outcomes of infants with short-chain acyl-coenzyme A dehydrogenase deficiency (SCADD) detected by newborn screening.通过新生儿筛查检测出的短链酰基辅酶A脱氢酶缺乏症(SCADD)婴儿的临床结局。
Mol Genet Metab. 2008 Dec;95(4):241-2. doi: 10.1016/j.ymgme.2008.09.003. Epub 2008 Oct 23.
5
The ACADS gene variation spectrum in 114 patients with short-chain acyl-CoA dehydrogenase (SCAD) deficiency is dominated by missense variations leading to protein misfolding at the cellular level.114例短链酰基辅酶A脱氢酶(SCAD)缺乏症患者的ACADS基因变异谱以错义变异为主,这些变异导致细胞水平上的蛋白质错误折叠。
Hum Genet. 2008 Aug;124(1):43-56. doi: 10.1007/s00439-008-0521-9. Epub 2008 Jun 4.
6
Role of short-chain hydroxyacyl CoA dehydrogenases in SCHAD deficiency.短链羟酰基辅酶A脱氢酶在SCHAD缺乏症中的作用。
Biochem Biophys Res Commun. 2008 Mar 28;368(1):6-11. doi: 10.1016/j.bbrc.2007.10.188. Epub 2007 Nov 26.
7
Spontaneous development of intestinal and colonic atrophy and inflammation in the carnitine-deficient jvs (OCTN2(-/-)) mice.肉碱缺乏的jvs(OCTN2(-/-))小鼠肠道和结肠萎缩及炎症的自发发展
Mol Genet Metab. 2007 Dec;92(4):315-24. doi: 10.1016/j.ymgme.2007.08.002. Epub 2007 Sep 19.
8
Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study.澳大利亚新生儿中链酰基辅酶A脱氢酶缺乏症筛查的结果:一项队列研究。
Lancet. 2007 Jan 6;369(9555):37-42. doi: 10.1016/S0140-6736(07)60029-4.
9
Reye-like syndrome resulting from novel missense mutations in mitochondrial medium- and short-chain l-3-hydroxy-acyl-CoA dehydrogenase.线粒体中链和短链L-3-羟基酰基辅酶A脱氢酶新的错义突变导致的瑞氏综合征样综合征。
Mol Genet Metab. 2006 Sep-Oct;89(1-2):74-9. doi: 10.1016/j.ymgme.2006.04.004. Epub 2006 May 24.
10
Fatty acid oxidation in the human fetus: implications for fetal and adult disease.人类胎儿中的脂肪酸氧化:对胎儿及成人疾病的影响。
J Inherit Metab Dis. 2006 Feb;29(1):71-5. doi: 10.1007/s10545-006-0199-x.